Life Sciences Greenhouse Investments
lsgpa.com Direct investor
Life Sciences Greenhouse Investments is an evergreen venture fund created in 2002 through Pennsylvania legislation to invest in early-stage life science companies. It provides capital and operational advice to companies connected to Pennsylvania.
Life Sciences Greenhouse Investments is a public fund headquartered in Harrisburg, United States, founded in 2002. It invests directly in companies, from pre-seed to Series B, in drug discovery, diagnostics, devices and manufacturing tools. Its stated cheque size is $250,000-$500,000 typical; up to $1.5 million (occasionally more); up to $5 million. 86 portfolio companies, as it reports.
“We focus on early-stage companies that are working on drug discovery, diagnostics, and devices, as well as tools that facilitate manufacturing at scale in these three areas.”
— Life Sciences Greenhouse Investments, own website
- Layer
- Direct investor
- Type
- Public fund
- Headquarters
- Harrisburg, United States
- Invests in
- Pennsylvania
- Sectors
- drug discovery, diagnostics, devices, manufacturing tools, healthcare IT
- Cheque size
- $250,000-$500,000 typical; up to $1.5 million (occasionally more); up to $5 million
- Founded
- 2002
- Portfolio
- 86 companies
Team, as Life Sciences Greenhouse Investments publishes it
- Michele Washko, M.B.A. President & CEO
- Greg Jackson, Ph.D. Executive Vice President
- Stephanie Reisinger Board Chair
- Jennifer Gilburg, MS Deputy Secretary, Technology and Entrepreneurship PA Department of Community and Economic Development
- James V. Manser Vice President, Global Government Relations, Johnson Controls International
- Jon Morris, MD Vice President, IQVIA
- R. Sam Niedbala, PhD CEO, CryoConcepts LP
- Jeffrey Snellenburg President, Pennsylvania Angel Network and Executive Director, Mid-Atlantic Angel Group
- Rebecca Stametz, DEd, MPH Vice President Digital Transformation, Geisinger Steele Institute for Health Innovation
- Nishit Trivedi, PhD, MBA, MBBS Director, Life Sciences, Emerald Advisers
- Haichen Yang, MD, MA, MBA Vice President Clinical Research, Amicus Therapeutics
Names and roles exactly as listed on lsgpa.com. Nothing else about these people is recorded.
Where this comes from
Every fact above was read from a page Life Sciences Greenhouse Investments publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.
- https://www.lsgpa.com/name, hq_country, hq_city, cheque_size, status, confidence
- https://www.lsgpa.com/aboutis_investor, layer, type, stage_min, stage_max, description, founded, portfolio_count
- https://www.lsgpa.com/fundinginvests_in_geographies, sectors, thesis_quote
- https://www.lsgpa.com/our-teampeople
Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.
Record 16048 · added 2026-10-21 · link last verified 2026-10-21 · confidence high
Similar investors
- Ben Franklin Technology PartnersPublic fund · Seed – Growth · Harrisburg, United States
- America's Seed Fund (NSF SBIR/STTR)Public fund · Seed – Series A · Alexandria, United States
- Community Development Financial Institutions FundPublic fund · Washington, United States
- Impulsora del Fondo México, S.C.Public fund · Columbia, United States
- Innovation WorksPublic fund · Pre-seed – Seed · Pittsburgh, United States
- Inter-American FoundationPublic fund · Washington, United States